Recipharm to potentially end operations in Ashton-under-Lyne facility
Recipharm today announces that it will initiate a process to explore the discontinuance of operations at its solid dose manufacturing facility in Ashton-under-Lyne, UK. The decision to initiate this process has been taken following a strategic review of the operation which has not been profitable for several years. The facility employs approximately 140 people and if a final decision is taken to discontinue operations these people are likely to affected. As part of this activity, appropriate consultation with employees will now commence. Recipharm will also discuss with clients the